<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0002858'>Meningioma</z:hpo>-associated protein (MAC30), first described to be overexpressed in <z:hpo ids='HP_0002858'>meningiomas</z:hpo>, exhibits altered expression in certain human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of our study was to investigate the expression of MAC30 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and its correlation with clinicopathological variables in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: MAC30 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was first examined in 55 CRCs, along with the samples from the matched distant <z:mpath ids='MPATH_458'>normal</z:mpath> and adjacent noncancerous tissue by RT-PCR, further verified in 18 CRCs by quantitative RT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>MAC30 protein expression was detected by Western blot in 10 CRCs, and DNA sequencing was performed in 1 case of the paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and the matched noncancerous specimen </plain></SENT>
<SENT sid="4" pm="."><plain>MAC30 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in two <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines, HCT-116(p53-/-) and HCT-116(p53+/+), was detected by quantitative RT-PCR </plain></SENT>
<SENT sid="5" pm="."><plain>Results: The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of MAC30 was increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> when compared with distant <z:mpath ids='MPATH_458'>normal</z:mpath> (p &lt; 0.01) and adjacent noncancerous mucosa (p &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean value of MAC30 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> located in the colon was higher than in the rectum (0.677 ± 0.419 vs. 0.412 ± 0.162, p = 0.005) </plain></SENT>
<SENT sid="7" pm="."><plain>As the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> penetrated the wall of the colon/rectum, MAC30 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression notably increased in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with T3+T4 stage compared to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with T1+T2 stage (0.571 ± 0.364 vs. 0.404 ± 0.115, p = 0.014) </plain></SENT>
<SENT sid="8" pm="."><plain>MAC30 protein expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> was also remarkably elevated compared to the adjacent noncancerous mucosa </plain></SENT>
<SENT sid="9" pm="."><plain>There was no mutation in the coding region of the MAC30 gene either in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> or in the noncancerous mucosa </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of p53 was notably decreased in HCT-116(p53-/-) compared to HCT-116(p53+/+), while MAC30 did not vary greatly </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The overexpression of MAC30 might be involved in the development and <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, especially in the colon </plain></SENT>
</text></document>